Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody
about
A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infectionGenome analysis of a highly virulent serotype 1 strain of Streptococcus pneumoniae from West AfricaVaccine against arteriosclerosis: an update.Pneumococcal carriage results in ganglioside-mediated olfactory tissue infection.Role of genetic resistance in invasive pneumococcal infection: identification and study of susceptibility and resistance in inbred mouse strains.Requirement for capsule in colonization by Streptococcus pneumoniae.Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae.IRAK-4 and MyD88 deficiencies impair IgM responses against T-independent bacterial antigensAntipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens.Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(DL-lactide-co-glycolide) microspheresHighly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse.Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae.Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.Novel surface attachment mechanism of the Streptococcus pneumoniae protein PspAProtection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several typesAnti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae.Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae.Positive correlation between tyrosine phosphorylation of CpsD and capsular polysaccharide production in Streptococcus pneumoniae.Peritoneal challenge modulates expression of pneumococcal surface protein C during bacteremia in mice.Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniaeSCID-Hu mice immunized with a pneumococcal vaccine produce specific human antibodies and show increased resistance to infection.Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae.Enhancement of mucosal antibody responses to Salmonella typhimurium and the microbial hapten phosphorylcholine in mice with X-linked immunodeficiency by B-cell precursors from the peritoneal cavity.Protective murine monoclonal antibodies to Cryptococcus neoformansX-linked immunodeficient mice as a model for testing the protective efficacy of monoclonal antibodies against Pseudomonas aeruginosa.Rabbit antibodies to the cell wall polysaccharide of Streptococcus pneumoniae fail to protect mice from lethal challenge with encapsulated pneumococci.Correlation of serum opsonins with in vitro phagocytosis of Streptococcus pneumoniaeProtection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide.Animal models of Streptococcus pneumoniae diseaseEpidemiological studies of Streptococcus pneumoniae in infants: development of antibody to phosphocholine.A modified surface killing assay (MSKA) as a functional in vitro assay for identifying protective antibodies against pneumococcal surface protein A (PspA).Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseasesMicrobial modulation of host immunity with the small molecule phosphorylcholine.Differences in virulence for mice among Streptococcus pneumoniae strains of capsular types 2, 3, 4, 5, and 6 are not attributable to differences in pneumolysin production.PD-L2 Regulates B-1 Cell Antibody Production against Phosphorylcholine through an IL-5-Dependent Mechanism.Ultrastructural localization of capsules, cell wall polysaccharide, cell wall proteins, and F antigen in pneumococci.Monoclonal phosphorylcholine antibody binds to beta-lipoprotein from different animal species.Determination of antibodies to pneumococcal C polysaccharide in patients with community-acquired pneumonia.A bivalent vaccine to protect against Streptococcus pneumoniae and Salmonella typhi.The Pathogenic Potential of a Microbe.
P2860
Q24646925-A78951BD-ADB0-430E-A026-3847DBB86187Q27315098-DF5BA2C3-4C10-4103-B790-2C74AB46DC94Q33641227-E1AAB57E-CDC1-4ECC-8181-957A934FF493Q33717128-9748971C-02B3-46E2-829A-4BA7FD8D8374Q34005696-40AD324E-661C-48FA-B8A4-64A08DA826FEQ34007742-A33239BF-F591-4597-B02F-25E585C35A62Q34521565-E850C066-9E8E-4D8F-A98B-329D0A43529AQ34636867-E28D3E96-F73D-4799-A8EA-0114B2F50F3DQ35095675-306A99FB-7BC9-452D-A018-62B940DCDDE6Q35543832-52EFF647-17E0-4A85-8FD8-855DC18CFB7BQ35758346-DF69B147-A802-41FE-9F14-C4A6971D0338Q35779863-67761F4E-F680-488D-B929-676581D42FC6Q35805480-C875E5EE-836B-4574-A988-2E9389D5981DQ36107664-4E983B44-E5B3-4062-A0E3-FCA73535942EQ36345169-2F39088B-8AB5-4269-83BC-75EAB887325BQ36346976-7A19ABC6-C2EF-4480-BCF3-3ECEA52D0BA2Q36349356-2D42682A-A4CC-4494-9613-38540829E20DQ36474326-3A783B1E-2DAE-4B22-88E0-B5966A4657CAQ36483562-2117D4DC-7F07-40CE-B99B-D35533BCC284Q36945140-A2E4AF9A-5B51-4A06-AA9F-729822556AFDQ36951729-38D85F17-0D09-4971-9746-3FBC84484C04Q36953957-85826D16-CE2D-4518-BE01-916E5732A6AFQ36957837-AC88D833-5358-420C-ACDF-D4C9D0E56781Q36969771-85AD3C23-8AD4-4BA2-BCCF-F3F6600BD561Q37004355-D4FB054A-8E8C-48CF-98DD-98DC58959F96Q37013271-0A5F12A2-3B46-4C01-ACC7-4EA4A0133EA0Q37053139-4A211673-43EC-4BE4-9526-4E16403605D0Q37191236-D165B500-CDAB-490E-A693-834CACC66714Q37293669-9FE110CB-0EA6-4933-9841-E5EAAA40A1B6Q37309362-684ED542-6829-4937-8A82-AE98BC3AD753Q37483596-465BA24C-AA9C-4502-8ED2-942CFB0B6E12Q37709623-A0FFEC83-E4FF-4A77-8C74-4AE7FD5A5FC6Q38066467-8DB92BC2-FF9B-493B-BDF7-F22C96C9A1F4Q39829400-6A7BF378-34D5-4190-BD8A-890607BAFD61Q40109527-8CCD9FB0-25CF-4E8F-9129-3F76EFA87DDDQ40158415-A8562483-7AC8-4BF4-9528-F2834A82BB50Q40165025-5BAC0531-5494-4F60-AF1A-1656771F99C3Q40204722-B74A912E-9AC2-449E-8A49-4ABBC839B4D5Q40291567-F160A21E-9F1B-4622-937C-573630CCFCC2Q40311700-33A0EC72-8743-48BF-B852-7198B3AC8D35
P2860
Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh
1982年學術文章
@zh-hant
name
Protection of mice from infect ...... y anti-phosphocholine antibody
@ast
Protection of mice from infect ...... y anti-phosphocholine antibody
@en
type
label
Protection of mice from infect ...... y anti-phosphocholine antibody
@ast
Protection of mice from infect ...... y anti-phosphocholine antibody
@en
prefLabel
Protection of mice from infect ...... y anti-phosphocholine antibody
@ast
Protection of mice from infect ...... y anti-phosphocholine antibody
@en
P2093
P2860
P1476
Protection of mice from infect ...... y anti-phosphocholine antibody
@en
P2093
P2860
P304
P407
P577
1982-04-01T00:00:00Z